Stephen B. Montgomery

Generalizability of proteomic risk prediction across biobanks reveals dependence on phenotype definitions

Advances in high-throughput proteomics technologies have enabled the assessment of dynamic health states across biobank-scale cohorts. Disease prediction models built on these data have higher accuracy than baseline clinical models for a broad range of diseases, and provide avenues to understand disease pathogenesis. H...